Mirtazapine Reduces ICD Shocks in ICD Patients With Depression and Anxiety

• Status: Completed
• Trial end date: 2008-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate if the use of antidepressant medication in depressed patients with implantable cardioverter defibrillator reduces the number of ICD's shocks as it improves depressive affect.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universidad Nacional de Rosario
• Treatments: Mianserin; Mirtazapine

Criteria

Inclusion Criteria:

• cardioverter implanted patients

• depression

• anxiety

Exclusion Criteria:

• heart failure

• other diseases reducing physical fitness